A logo

A Agilent Technologies, Inc.

New York Stock Exchange · Medical - Diagnostics & Research · Healthcare

$148.55
-0.74 (-0.49%)

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry…

Market Cap: $41.96Bwww.agilent.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

80
80
Aug 15Aug 15

Quote

Day Range
$147.43 – $149.16
52-Week Range
$108.35 – $160.27
Volume
$524.8K
Market Cap
$41.96B
50-Day Avg
$135.42
200-Day Avg
$131.07
Prev Close
$149.29
Open
$148.52

Valuation & Ratios

P/E Ratio
31.89
EPS
$4.60
P/B Ratio
6.14
P/S Ratio
5.96
Debt/Equity
0.50
Current Ratio
1.96
Dividend Yield
+0.7%
Gross Margin
+52.4%

Returns & Efficiency

Return on Equity
+19.3%
Return on Assets
+10.2%
FCF Yield
+2.8%
EV/EBITDA
23.43

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$6.95B$1.30B$4.59
2024$6.51B$1.29B$4.44
2023$6.83B$1.24B$4.22
2022$6.85B$1.25B$4.19
2021$6.32B$1.21B$3.98

Social Signal Score

30
5d
30
1 mentions
30d
30
1 mentions
60d
30
1 mentions
90d
30
1 mentions
news: 1

Earnings

Wed, Aug 26(in 10 days)

Consensus estimate $1.49 per share

6of 7 quarters beat consensus

Typical surprise +2.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, May 27$1.49 vs $1.41beat
  • Wed, Feb 25$1.36 vs $1.37miss
  • Mon, Nov 24$1.59 vs $1.58beat
  • Wed, Aug 27$1.37 vs $1.37beat
  • Wed, May 28$1.31 vs $1.26beat
  • Wed, Feb 26$1.31 vs $1.28beat

Estimates and results for A via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from A's reported EPS growth of 3.6% a year over 4 years.

EPS in 5 years
$5.49
Implied price
$175.84
Return from $148.55
3.4% a year

To earn 15.0% a year on these assumptions you'd need to buy at $87.42 -41.2% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E2227323742
-6.4%-13.3%-9.7%-6.6%-3.8%-1.3%
-1.4%-8.7%-4.9%-1.6%1.3%3.9%
3.6%-4.0%-0.0%3.4%6.5%9.2%
8.6%0.6%4.8%8.4%11.6%14.5%
13.6%5.2%9.6%13.4%16.8%19.8%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newsdefenseworld.net·11h ago·Negative

    Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A. Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE: A) by 75.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,454 shares of the medical research company's stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.'s

    View source ↗